Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.325 USD | -0.38% | -2.59% | -87.90% |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 17 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 39.35M | Sales 2025 * | 58.17M | Capitalization | 73.06M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -77M | EV / Sales 2024 * | -1.38 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 54.53M | EV / Sales 2025 * | 0.32 x |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
-1.28
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -2.63% | ||
1 week | -4.36% | ||
Current month | -8.43% | ||
1 month | -12.46% | ||
3 months | -86.47% | ||
6 months | -78.94% | ||
Current year | -88.12% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 1.31 | -1.50% | 421 407 |
24-05-17 | 1.33 | +2.31% | 1,305,323 |
24-05-16 | 1.3 | -2.26% | 926,244 |
24-05-15 | 1.33 | -0.75% | 1,079,563 |
24-05-14 | 1.34 | -0.74% | 1,196,671 |
Delayed Quote Nasdaq, May 20, 2024 at 09:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.12% | 73.06M | |
+33.14% | 693B | |
+29.39% | 584B | |
-3.00% | 372B | |
+20.44% | 332B | |
+6.79% | 294B | |
+14.28% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.26% | 168B |
- Stock Market
- Equities
- MRNS Stock